Affordable Care Act lowered uninsured rate for cancer survivors

February 15, 2018

February 15, 2018 - The percentage of cancer survivors without health insurance decreased substantially after implementation of the Affordable Care Act (ACA), reports a study in the March issue of Medical Care, published by Wolters Kluwer.

Cancer survivors eligible for Medicaid expansion under the ACA had the greatest decrease in uninsured rate, according to the new research by Amy J. Davidoff, PhD, of Yale School of Public Health, New Haven, Conn., and colleagues. They write, "ACA implementation was associated with large coverage gains in targeted expansion groups, including cancer survivors, but additional progress is needed."

Improved Access to Insurance for Cancer Survivors

The researchers analyzed data from a nationally representative survey collected before (2012-13) and after (2014-15) implementation of the major ACA coverage expansions. The study included approximately 93,000 adults under age 65. Of these, about 4,000 had a history of some type of cancer.

Changes in insurance coverage rates before and after the ACA were compared for subjects with and without a cancer history. The analysis included the effects of ACA provisions intended to increase access to health insurance, including eligibility for Medicaid and premium subsidies to purchase private coverage in the newly established insurance Marketplaces.

After ACA implementation, the uninsured rate among cancer survivors decreased by 4.7 percentage points: from 12.4 to 7.7 percent. That translated into a 38 percent relative decrease in the percentage uninsured.

The largest reduction in uninsured rate, 16.7 percentage points, was seen in cancer survivors who were eligible for Medicaid expansion under the ACA (relative to the "high-income" category not eligible for Medicaid or subsidies). Uninsured rates decreased by 11.3 percentage points among cancer survivors who were eligible for premium subsidies and by 8.4 percentage points among those who were eligible for Medicaid before the ACA.

However, even under these ACA provisions, millions of Americans still didn't have health insurance. "Despite coverage gains, approximately 528,000 cancer survivors and 19.1 million without a cancer history remained uninsured post-ACA, yet over half were eligible for Medicaid or subsidized Marketplace coverage," Dr. Davidoff and coauthors write.

Historically, cancer survivors have faced potential restriction on their access to insurance--largely due to loss of employment-based insurance or because having a history of cancer made health insurance unavailable or unaffordable. Cancer survivors need ongoing medical care and follow-up, which may be compromised if they don't have health insurance. "Ensuring access to insurance coverage for cancer survivors is of critical importance to improve cancer-related outcomes," Dr. Davidoff and colleagues write.

The results show substantial reductions in the uninsured rate for adult cancer survivors under the ACA, especially those eligible for Medicaid coverage and premium subsidies. However, many cancer survivors are still not covered--particularly in states that did not expand Medicaid. Dr. Davidoff and coauthors conclude: "Given the potentially longer-term time frame to observe some health benefits, it is essential to monitor the ongoing effects of healthcare reform on insurance coverage and impacts on cancer stage at diagnosis, treatment, and outcomes and to continue to explore ways to improve cancer care."
-end-
Click here to read "Changes in Health Insurance Coverage Associated With the Affordable Care Act Among Adults With and Without a Cancer History: Population-based National Estimates."

DOI: 10.1097/MLR.0000000000000876

About Medical Care

Rated as one of the top ten journals in health care administration, Medical Care is devoted to all aspects of the administration and delivery of health care. This scholarly journal publishes original, peer-reviewed papers documenting the most current developments in the rapidly changing field of health care. Medical Care provides timely reports on the findings of original investigations into issues related to the research, planning, organization, financing, provision, and evaluation of health services. In addition, numerous special supplementary issues that focus on specialized topics are produced with each volume. Medical Care is the official journal of the Medical Care Section of the American Public Health Association

About Wolters Kluwer

Wolters Kluwer N.V. (AEX: WKL) is a global leader in information services and solutions for professionals in the health, tax and accounting, risk and compliance, finance and legal sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with specialized technology and services.

Wolters Kluwer reported 2016 annual revenues of €4.3 billion. The company, headquartered in Alphen aan den Rijn, the Netherlands, serves customers in over 180 countries, maintains operations in over 40 countries and employs 19,000 people worldwide.

Wolters Kluwer Health is a leading global provider of information and point of care solutions for the healthcare industry. For more information about our products and the organization, visit http://www.wolterskluwer.com/, follow @WKHealth or @Wolters_Kluwer on Twitter, like us on Facebook, follow us on LinkedIn, or follow WoltersKluwerComms on YouTube.

For more information about Wolters Kluwer's solutions and organization, visit http://www.wolterskluwer.com, follow us on Twitter, Facebook, LinkedIn, and YouTube.

Wolters Kluwer Health

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.